Marathon's Richards Says Equities Can Absorb 25 Bps Fed Hike
Original Report
Markets can withstand a 25 basis-point interest-rate increase by the Federal Reserve, according to Marathon Asset Management CEO Bruce Richards. "The consumer is doing well, corporate earnings are...
Markets can withstand a 25 basis-point interest-rate increase by the Federal Reserve, according to Marathon Asset Management CEO Bruce Richards. "The consumer is doing well, corporate earnings are doing well, the economy is doing well," Richards says on Bloomberg Television. (Source: Bloomberg)
Glass House Analysis
Central bank policy decisions made in boardrooms cascade through the economy in ways that touch everyone. A quarter-point rate change might seem abstract, but it determines whether young families can afford homes, whether businesses can afford to hire, and whether retirees see meaningful returns on their savings. The tension between fighting inflation and maintaining employment represents a fundamental tradeoff in economic policy—one that invariably creates winners and losers.
Corporate decisions reverberate through local communities—a merger might mean headquarters relocating, a restructuring could eliminate jobs, and strategic shifts affect suppliers and service providers in countless towns. Behind quarterly earnings numbers are real employment decisions, investment choices, and community impacts that shape the economic landscape of regions across the country.
The implications extend beyond the immediate news cycle. Every economic development creates ripples that affect employment, prices, and opportunities in ways that may not be immediately visible but are deeply felt. By tracking these connections, we can better understand how the economy truly works—not as an abstract machine, but as a human system shaped by and shaping the lives of millions.
Enjoyed this analysis?
Get the Glass House Briefing every morning—market news that actually makes sense, delivered free to your inbox.
No spam. Unsubscribe anytime.
More Stories
TPB cancels C&N Southwest Sydney registration over conduct breaches
Pharma major Novartis falls 9% after three drug trial setbacks
Shares of Novartis tanked on Tuesday after results from its del-desiran drug trial disappointed investors.
U.S. stocks usually stumble after Fed hikes, but these markets tend to climb, says Citi
The relative returns for Japanese and U.K. equities reach between 2% and 3% on average following the first interest-rate raise in a hiking cycle by the Federal Reserve.
Dow futures fall 400 points to start shortened week as oil prices climb: Live updates
Wall Street is keeping tabs on the Middle East war and rising trade tensions between Canada and the U.S.